OverviewSuggest Edit

Medite Cancer Diagnostics specializes in the development, manufacture and distribution of medical laboratory instruments for pathology, histology and cytology. Medite offers consumable products and equipment in particular for Liquid Based Cytology which is the important tool in cancer screening and detection in the field of cervical, breast, lung and other cancer types.

TypePublic
Founded1998
HQOrlando, US
Websitemedite-group.com

Locations

Medite Cancer Diagnostics is headquartered in
Orlando, United States

Location Map

Latest Updates

Employees (est.) (Sept 2017)5
Revenue (FY, 2017)$6.8 M(-26%)
Share Price (May 2020)$0 (-10%)

Key People/Management at Medite Cancer Diagnostics

Michael Kenealy

Michael Kenealy

U.S. Director of Sales
Gary Pickett

Gary Pickett

CFO
Show more

Medite Cancer Diagnostics Office Locations

Medite Cancer Diagnostics has an office in Orlando
Orlando, US (HQ)
4203 34th St
Show all (1)

Medite Cancer Diagnostics Financials and Metrics

Medite Cancer Diagnostics Revenue

Medite Cancer Diagnostics's revenue was reported to be $6.81 m in FY, 2017
USD

Revenue (Q3, 2018)

2.4m

Gross profit (Q3, 2018)

1.5m

Gross profit margin (Q3, 2018), %

61.4%

Net income (Q3, 2018)

(735.0k)

EBIT (Q3, 2018)

(95.0k)

Market capitalization (21-May-2020)

2.3m

Closing stock price (21-May-2020)

0.0

Cash (30-Sept-2018)

147.0k

EV

7.9m
Medite Cancer Diagnostics's current market capitalization is $2.3 m.
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

24.0k198.0k24.0k11.0m9.9m9.2m6.8m

Revenue growth, %

(7%)

Cost of goods sold

104.0k8.0k7.2m6.1m5.6m6.7m

Gross profit

94.0k16.0k3.8m3.8m3.6m162.0k
Quarterly
USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Revenue

7.0k5.0k24.0k106.0k61.0k11.0k4.0k5.0k3.0k3.2m2.8m2.3m2.1m2.7m2.1m2.8m2.3m1.9m1.3m1.7m1.5m2.3m2.4m

Cost of goods sold

16.0k54.0k39.0k6.0k1.0k1.4m1.2m1.4m1.2m1.5m1.2m1.5m1.3m1.2m1.2m1.3m1.2m1.2m925.0k

Gross profit

7.0k8.0k52.0k22.0k5.0k4.0k4.0k3.0k1.7m1.6m918.0k966.0k1.2m918.0k1.3m1.0m680.0k49.0k369.0k335.0k1.1m1.5m

Gross profit Margin, %

100%33%49%36%45%100%80%100%55%57%40%45%44%43%45%43%36%4%22%22%47%61%
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

15.0k39.0k1.0k230.0k587.0k108.0k73.0k

Accounts Receivable

5.0k134.0k10.0k2.0m1.8m66.7m453.0k

Prepaid Expenses

10.0k10.0k5.0k154.0k186.0k118.0k

Inventories

3.4m3.1m3.8m2.4m
USDY, 2018

EV/EBIT

-83.2 x

EV/CFO

-2.3 x

Debt/Equity

0.9 x

Debt/Assets

0.3 x

Financial Leverage

2.7 x
Show all financial metrics

Medite Cancer Diagnostics Online and Social Media Presence

Embed Graph

Medite Cancer Diagnostics Frequently Asked Questions

  • When was Medite Cancer Diagnostics founded?

    Medite Cancer Diagnostics was founded in 1998.

  • Who are Medite Cancer Diagnostics key executives?

    Medite Cancer Diagnostics's key executives are Michael Kenealy and Gary Pickett.

  • How many employees does Medite Cancer Diagnostics have?

    Medite Cancer Diagnostics has 5 employees.

  • What is Medite Cancer Diagnostics revenue?

    Latest Medite Cancer Diagnostics annual revenue is $6.8 m.

  • What is Medite Cancer Diagnostics revenue per employee?

    Latest Medite Cancer Diagnostics revenue per employee is $1.4 m.

  • Who are Medite Cancer Diagnostics competitors?

    Competitors of Medite Cancer Diagnostics include ICU Medical, Accuray and Eigen.

  • Where is Medite Cancer Diagnostics headquarters?

    Medite Cancer Diagnostics headquarters is located at 4203 34th St, Orlando.

  • Where are Medite Cancer Diagnostics offices?

    Medite Cancer Diagnostics has an office in Orlando.

  • How many offices does Medite Cancer Diagnostics have?

    Medite Cancer Diagnostics has 1 office.